While a patient taking liraglutide does not have an eating disorder diagnosis by default, the pharmacologically induced appetite suppression can mimic the metabolic conditions (prolonged fasting, low blood sugar, electrolyte depletion) that raise seizure risk
The placebo group lost 2.1% of body weight
Brush JE, Krumholz HM , Wright JS, Brindis RG, Cacchione JG, Drozda JP, Fasules JW, Flood KB, Garson A, Masoudi FA, McBride T, McKay CR, Messer JV, Mirro MJ, OToole M, Peterson ED, Schaeffer JW, Valentine CM
Arif Hafsa, Roughly 1M Canadians use Ozempic, similar drugs for weight loss, diabetes: study, CTVNews
Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths: a prospective analysis